跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RELISTOR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RELISTOR
Authorized
STANDARD
RELISTOR
SALIX PHARMACEUTICALS INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
35fe7b47d6ad1b95
Company
SALIX PHARMACEUTICALS INC
Type
Standard
Approval Details
Approval Id
35fe7b47d6ad1b95
Drug Approval Canada Name
RELISTOR
Product Name
RELISTOR
Status
Approved
Status Date
2012-02-03
Din
02356503
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
56:92.00
Atc Original
A06AH01 METHYLNALTREXONE BROMIDE
Atc Name
a 06 ah 01
Aig Number
0152456001
Company Name
SALIX PHARMACEUTICALS INC
Company Address
400 Somerset Corporate Boulevard, Bridgewater, New Jersey, United States, 08807
Company Detail Path
/organization/salix-pharmaceuticals-inc-ridgeland-mississippi-united-states
Company Information
Pharmaceutical Company Name
SALIX PHARMACEUTICALS INC
Country Name
United States
Province Name
Mississippi
City Name
ridgeland,mississippi,country_us
Address
291 Highway 51 Ste A7
Active Ingredients
METHYLNALTREXONE BROMIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
35fe7b47d6ad1b95
Type
Standard
Back to Health Canada Approvals